Clinical Trials
Braintumor Website

There are 8 trials:
Facility: Centre Henri Becquerel
NCT Trial Name# of Centers

NCT01835236

  Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
74

NCT01564056

  Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment
72

NCT01442662

  Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas
19

NCT01303497

  Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas
19

NCT01414933

  High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents
18

NCT00553943

  Phase II Study to Evaluate the Combination of Rituximab and DepoCyte┬« in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis
7

NCT01332929

  Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin┬«) for Treatment of Brain Metastasis
4

NCT02617745

  Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites